Reserpine

Quick links to important sections

Reserpine

Selected form

Treatment option: Psychosis

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Reserpine

Property Description
Active ingredient Reserpine (INN)
Form Oral preparations (predominantly tablets)
Pharmacological class Antihypertensive Agent, Sympatholytic Agent, Rauwolfia Alkaloid
Common use Reduction of chronic high blood pressure (hypertension)
Origin Naturally occurring indole alkaloid from the Rauwolfia serpentina plant

What Type of Medicine is Reserpine? (Class, Identity, and Form)

Reserpine is a single-ingredient, prescription medication classified as an Antiadrenergic agent, Centrally Acting and is specifically grouped under the Rauwolfia alkaloids. It is clinically recognized for its role as a sympatholytic agent within the broader class of antihypertensive medications. The drug is typically presented as an oral preparation, predominantly tablets, which defines its identity for systemic administration. This Reserpine entity is a foundational medicine whose therapeutic effects have been observed in pharmacological contexts for several decades.

Is Reserpine Natural or Synthetic? (Origin and Composition)

The active substance, Reserpine (INN), is an indole alkaloid derived from a natural source, the roots of the Rauwolfia serpentina plant, a traditional medicinal herb. This distinction in origin sets it apart from many contemporary synthetic blood pressure medications. The final product is based on this purified Reserpine substance, typically formulated within a neutral pharmaceutical excipient matrix to create the solid oral dosage form.

What is the General Purpose of Reserpine? (High-Level Benefit)

The fundamental general purpose of Reserpine is to manage and reduce chronically high blood pressure (hypertension). It achieves this by functioning as a monoamine depletor, a unique mechanism that gently reduces the storage levels of stimulating chemical messengers, such as norepinephrine, within nerve endings. By exerting this modulatory effect on the adrenergic nervous system, Reserpine reduces the overall resistance to blood flow. Therefore, the medication offers a way to target the sympathetic nervous system to reduce cardiovascular strain.

What side effects are possible with Reserpine?

Possible Side Effects and Safety Information

The official safety profile for Reserpine includes adverse reactions that affect multiple body systems, most prominently the central nervous system (CNS) and the gastrointestinal tract. Regulatory documents categorize these effects based on frequency and severity.

Common and System-Specific Reactions

Adverse effects listed as common or frequent in regulatory labeling include nasal congestion, which is a widely noted autonomic effect, along with headache, dizziness, drowsiness, and bradycardia (slowed heart rate). The gastrointestinal system is often affected, resulting in symptoms such as nausea, vomiting, diarrhea, and increased gastric secretion. Effects on the reproductive system, such as impotence and decreased libido, are also documented.

Serious Adverse Reactions and Restrictions

Reserpine's official safety profile places a critical emphasis on Mental Depression, which is classified as a serious adverse reaction. This reaction may arise at any time during treatment and carries the explicit regulatory risk of suicidal ideation and action, necessitating immediate discontinuation if symptoms appear. Other serious reactions include cardiac arrhythmias (especially with concurrent use of digitalis or quinidine) and, rarely, extrapyramidal tract symptoms (e.g., Parkinsonian syndrome).

Safety Constraints and Population Notes

The medicine is subject to specific regulatory constraints. It is formally contraindicated in individuals with a history of mental depression, active peptic ulcer, ulcerative colitis, or advanced hepatic failure. Furthermore, regulatory notes clarify that the drug-induced depression may persist for several months after the medicine is withdrawn, and higher doses are generally advised against in older adults.

Overdose and Emergency Response

The regulatory information outlines the potential for severe outcomes following an overdose of Reserpine, mandating specific emergency actions.

Documented Overdose Presentations: Clinical signs are characterized by a reflex parasympathomimetic effect, including flushing of the skin, pupillary constriction, conjunctival injection, increased salivary and gastric secretion, and diarrhea.
Life-Threatening Outcomes: Overdosage may lead to severe hypotension (critically low blood pressure), severe bradycardia (slow heart rate), hypothermia, and central respiratory depression. Impairment of consciousness may range from drowsiness to coma.
Emergency Action Required (As Labeled): Immediate medical attention must be sought upon any suspicion of overdosage or the development of severe symptoms. The patient must be observed carefully for at least 72 hours due to the drug's sustained effects.

Official Overdose Statements

  • No specific antidote is known for Reserpine overdose.
  • Treatment is focused on supportive care, which includes stomach contents evacuation and the instillation of activated charcoal slurry.
  • If severe hypotension requires intervention, a direct-acting vasopressor may be necessary.

Connection to the Overall Overdose Profile

The official profile defines overdose as a high-risk medical emergency due to the potential for profound cardiovascular and central nervous system depression. As no specific antidote exists, the mandated response centers on immediate supportive care, procedural measures, and continuous extended monitoring to manage life-threatening symptoms.

Therapeutic Uses of Reserpine

Reserpine's therapeutic utility is centered on providing supportive relief for conditions related to chronic nervous system overactivity. It is relevant in clinical settings marked by heightened physiological stress or severe symptomatic manifestations.


What Reserpine Treats: Main Uses and Benefits

Reserpine is utilized in the management of persistent hypertension, especially severe cases that are refractory to initial therapies, contributing to the reduction of persistently elevated pressure. It is also used as an adjunctive treatment for specific agitated psychotic states. These indications, which involve conditions characterized by heightened symptoms, are generally addressed in scenarios where additional symptomatic support is needed.

The key benefit is assisting with the reduction of strain on the heart and arteries, which may assist with managing the long-term risk associated with cardiovascular strain. Furthermore, it may offer a tranquilizing effect that helps moderate intense agitation.

“It is commonly used to help with symptoms related to both severe blood pressure fluctuations and certain related behavioral manifestations.”

Quick Fact: Relief for Heightened Physiological Activity


QuickFact Block

Quick Fact: Relief for Heightened Physiological Activity
Symptom Domains Addressed Elevated systemic vascular resistance and excessive sympathetic tone.
Clinical Scenarios Used in combination therapy for refractory hypertension and as adjunctive support for severe psychological excitement.
Patient Benefit Contributes to improved comfort during symptomatic periods and assists with maintaining functional stability.

Regulatory References

  1. NIH MedlinePlus overview on Reserpine

Eligibility and Restrictions for Use

Eligibility and Restriction Summary

Reserpine's official eligibility profile is strictly defined by regulatory authorities to determine which populations may use the medicine and which are absolutely prohibited. Use is established for adults managing hypertension and specific severe agitated psychotic states. Conversely, the medicine is contraindicated and must not be used in specific patient groups.

Absolute contraindications include individuals with a known hypersensitivity to the drug, a history of mental depression (especially with suicidal tendencies), active peptic ulcer, or ulcerative colitis. Use is also prohibited for patients currently undergoing electroconvulsive therapy (ECT).

Specific age groups and conditions require limited or conditional use. Reserpine is not recommended as routine treatment for hypertension in older adults due to increased risk of certain adverse effects. For women who are pregnant, the drug is classified as FDA Pregnancy Category C, meaning use is restricted to cases where no safer alternatives exist. It is not recommended for use by nursing mothers, as the drug is excreted into human milk. Conditional use with caution is required for patients with renal insufficiency, a history of peptic ulcer/ulcerative colitis, or gallstones.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Reserpine, focusing strictly on restrictions and outcomes as defined by government drug labels.


Formal Contraindications and Restrictions

Co-administration with Monoamine Oxidase Inhibitors (MAOIs) is explicitly prohibited due to the risk of severe adverse reactions. Reserpine is also formally contraindicated with other monoamine-depleting agents, such as Tetrabenazine and Deutetrabenazine. For the latter, regulatory documents mandate a minimum 20-day separation period after discontinuing Reserpine before initiating treatment.


Pharmacodynamic and Pharmacokinetic Interactions

Pharmacodynamic Reinforcement: Reserpine may potentiate the effects of other substances. Co-administration with other antihypertensive agents can result in additive hypotensive effects. Likewise, combining it with Central Nervous System (CNS) depressants, including alcohol, may lead to enhanced sedation.

Sympathomimetic Agents: Reserpine alters the response to pressor drugs. It can inhibit the action of indirect-acting sympathomimetics, while potentially enhancing the response to direct-acting sympathomimetics.

P-glycoprotein Inhibition: Reserpine is documented as an inhibitor of the P-glycoprotein efflux transporter. This action can lead to increased plasma concentrations and exposure of co-administered medicines that are P-gp substrates.

Mechanism of Action

VMAT2 Inhibition and Irreversible Monoamine Depletion

Reserpine acts primarily as an irreversible inhibitor of the Vesicular Monoamine Transporter 2 (VMAT2), a protein essential for packaging neurotransmitters like norepinephrine into storage vesicles. By blocking this transport, the stimulating neurotransmitters are left unprotected in the nerve cell's cytoplasm where they are rapidly destroyed by the Monoamine Oxidase (MAO) enzyme. This destruction results in the long-term depletion of releasable monoamine stores in nerve endings.

Sympatholysis and Modulation of Autonomic Balance

The depletion of norepinephrine stores in peripheral nerve endings reduces the overall activity of the sympathetic nervous system (sympatholysis). This reduction in stimulating nerve signals leads to two main physiological outcomes: the widening of blood vessels (peripheral vasodilation) and a decrease in the force and rate of the heart's contraction. The combined effect on vascular tone and cardiac output constitutes the mechanism by which systemic pressure is influenced.

Mechanism Constraints: Delayed Onset

A critical feature of Reserpine’s mechanism is its irreversible binding to VMAT2, which necessitates the synthesis of new transporter proteins to restore normal nerve function. This cellular process requires a considerable period, resulting in a gradual progression to the maximal physiological consequence, which takes days to weeks, and a prolonged duration of action even after the drug is no longer present in the body.

Dosage and Administration Information

Instruction Map: How to use Reserpine — Administration Guidelines


Administration Scope

Property Instruction
Route of administration Oral administration is the route for the tablet form.
Dosing schedule Hypertension (Initial): 0.5 mg daily for 1 or 2 weeks. Maintenance: Reduced to 0.1 mg to 0.25 mg daily. Psychiatric Disorders: 0.1 mg to 1.0 mg daily, with dosage adjusted according to patient response.
Timing in relation to meals (if applicable) May be taken with meals or milk if gastrointestinal upset occurs.
Preparation requirements (if applicable) The medication is taken by mouth with water.
Age-group administration rules Pediatric: Not routinely recommended. If used, the recommended starting dose is 20 μg/kg daily, not to exceed 0.25 mg (total) daily. Renal Impairment: Not recommended, as elimination half-life may be significantly increased.
Missed-dose rules If a dose is missed and the next dose is almost due, the missed dose should be skipped; a double dose must not be taken.
Special procedural conditions The medicine should be discontinued one to two weeks prior to elective surgery. Full antihypertensive effects may take up to 3 weeks to fully develop.

Instruction Classifications (High-Level)

  • Administration method type: Oral (Tablet)
  • Frequency pattern: Once Daily
  • Use-context constraints: Requires consistent daily timing, defined maximum dose for pediatric use, and required pre-surgical discontinuation.

Resulting Procedural Structure

Step sequence:

  • The tablets are administered by the oral route once per day at a consistent time.
  • Treatment initiates with a specific higher daily dose for a short period (1–2 weeks), then transitions to a defined lower maintenance dose.
  • Dosing for psychiatric disorders involves titration within a prescribed range based on individual response.
  • If a dose is missed near the time of the next scheduled dose, standard practice is to skip the missed dose and proceed with the regular schedule.
  • Administration is not recommended for patients with renal dysfunction, and the medicine must be discontinued before elective surgery.

Connection to the overall use protocol: The established protocol defines a standardized oral administration process that dictates an initial course followed by a long-term maintenance dose, emphasizing once-daily frequency at a consistent time. This structure is accompanied by specific dose limits for pediatric patients and an explicit avoidance recommendation for individuals with renal impairment. The protocol further mandates the necessary pre-surgical discontinuation, defining the precise administrative constraints of the medicine.

Recent Clinical Evidence

Research evidence / Overview of studies for Reserpine

Evidence for use in Chronic High Blood Pressure (Hypertension)

Research for this use was evaluated across older, shorter-term randomized controlled trials (RCTs) and long-term clinical studies. The research examined Reserpine when used alone and as a component of combination therapy. Studies monitored outcomes related to physiological strain by measuring changes in blood pressure and, in long-term settings, monitored the frequency of clinical outcomes such as cardiovascular events. Findings were mixed across the small number of monotherapy RCTs. Long-term outcome data are largely derived from trials where Reserpine was evaluated as part of a combination regimen.

Research Focus on Agitated Psychotic States

The research base for this application is structured differently, relying largely on historical open clinical studies and observations that focused on documenting acute symptomatic changes. These reports described patterns of use, particularly in individuals who were unable to tolerate older treatments. However, the existing evidence for this application is limited. The evidence level remains low due to a lack of contemporary, high-quality methodologies and controlled comparisons. The certainty surrounding this evidence remains low, and the evidence base contributes to understanding historical symptom patterns.

Long-term Study Data and Follow-up and Specific Patient Groups

Studies examined long-term outcomes primarily when Reserpine was evaluated as part of combination therapy. Follow-up durations spanned several years, allowing researchers to monitor prolonged clinical outcomes. Data reflect these extended findings but show that long-term effects for Reserpine as a standalone monotherapy are not fully established. Research has evaluated specific groups, including older adults, but comparative evidence is lacking for many comorbidity-defined groups, and data reflect only the specific populations studied in the trials. A key overall limitation is the insufficient data from modern, well-controlled trials evaluating the drug when used alone.

Key Studies & References

  1. Reserpine (MedlinePlus Drug Information)
  2. Reserpine Tablet, label information (DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Reserpine (FAQ)

Q: What is the main difference between Reserpine and other high blood pressure treatments?

A: The core difference lies in how Reserpine acts on the nervous system. Official documents describe Reserpine as a unique medicine that works by reducing the amount of stimulating chemical messengers, like norepinephrine, stored in nerve endings. This mechanism is different from that of other classes of medicine, such as beta-blockers, which function by blocking receptors instead of depleting these messengers.


Q: Is Reserpine the same kind of medicine as a beta-blocker?

A: No, Reserpine is not classified as a beta-blocker. Reserpine belongs to a group called sympatholytics (Rauwolfia alkaloids), which work by reducing the storage of certain chemical messengers in nerve cells. In contrast, beta-blockers work by blocking specific receptors on cells. However, regulatory information notes that these two types of medicine can have additive effects when used together.


Q: Why do some people say Reserpine is an 'older' medication?

A: Reserpine is considered an older medicine because of its long history of use. The active ingredient is an alkaloid derived from the Rauwolfia serpentina plant, which has been used in traditional practices for centuries. It was one of the first medications used in modern medicine to treat chronic high blood pressure, with use dating back to the 1950s.


Q: Are there any special diet considerations when taking Reserpine?

A: Official labeling advises caution regarding certain substances. The product information notes that alcohol may enhance the sedative effects of the medicine due to its effects on the central nervous system (CNS). Regulatory information suggests that high intake of caffeine could potentially increase the risk of side effects like nervousness or palpitations while taking a CNS-acting drug.


Q: Are there warnings about driving or operating machinery while on Reserpine?

A: Regulatory warnings emphasize activities requiring focus. Because drowsiness and dizziness are known side effects, official safety information indicates that caution is necessary regarding driving a car or operating dangerous machinery. This is especially important during the initial phase of treatment or following any changes to the dosage.


Q: Is Reserpine available over-the-counter anywhere?

A: No, Reserpine is classified as a prescription-only medication. Official drug references indicate that it requires a prescription from a licensed healthcare provider for its use. It is not available for purchase over-the-counter.


Q: What does 'contraindication' mean in relation to Reserpine?

A: A contraindication is a specific condition or factor that absolutely prohibits the use of a medicine. According to official documents, it means the risk of using the drug under that condition outweighs any potential benefit. For Reserpine, specific contraindications listed in regulatory labeling include a history of mental depression, active peptic ulcer, and co-administration with MAO Inhibitors.


Q: What are the typical conditions for which Reserpine is used in combination therapy?

A: Studies and official guidelines describe Reserpine's use primarily in hypertension. It is often used as part of a multi-drug regimen for individuals with chronic high blood pressure. This approach is typically applied to patients with higher blood pressure classifications or when a single medicine has not achieved the desired results.


Q: Do official documents describe what happens if I take too much Reserpine?

A: Official documents outline the need for medical management in cases of overdosage. Regulatory information requires monitoring of vital signs, such as respiration and blood pressure. Supportive care is also recommended in the event that too much of the medicine is taken.


Q: Is there a generic version of Reserpine available?

A: Yes, a generic version of Reserpine is available. Official drug information, including FDA records, confirms that the medicine is manufactured by several companies as a generic oral preparation.


Q: What kind of monitoring is recommended when taking Reserpine?

A: Regulatory information notes that because Reserpine is associated with bradycardia (slowed heart rate) and carries a serious warning regarding mental depression, careful observation for changes in mood, heart function, and overall well-being is part of the therapy.


Q: Are there official statements about Reserpine and the risk of cancer?

A: Yes, official reports have addressed this subject. Reserpine is listed by the National Institutes of Health (NIH) in the Report on Carcinogens. This listing states the medicine is 'reasonably anticipated to be a human carcinogen,' based on sufficient evidence found in animal studies.


Q: Is it safe to drink coffee while on Reserpine?

A: Regulatory guidance notes that substances like caffeine are CNS stimulants. Warnings about interactions with CNS-acting drugs indicate that excessive intake could potentially increase the risk of side effects, such as nervousness or palpitations.


Q: How long does the effect of a Reserpine dose typically last?

A: The medicine has a prolonged effect on nerve chemistry. Official information indicates that Reserpine works by binding irreversibly to a target protein, meaning the effect on the nervous system lasts a long time. This prolonged action is the basis for why the medicine is typically prescribed for administration only once per day.


Q: Does Reserpine have any potential interactions with common pain relievers?

A: Regulatory information indicates potential interactions with certain pain relievers. Official documents mention that some pain relievers, including those containing aspirin, may potentially lessen the blood pressure-lowering effect of Reserpine. Pain relievers that cause drowsiness (CNS depressants) may also enhance the sedative effects of this medicine.


Q: Can Reserpine be taken safely with vitamins or herbal supplements?

A: The product label includes warnings about interactions with medicines that mimic the sympathetic nervous system (sympathomimetics). This suggests that supplements containing stimulating ingredients, such as certain high-caffeine products, are noted as a potential interaction risk.


Q: What is the reason Reserpine is sometimes prescribed along with a diuretic?

A: Reserpine is often used in combination therapy to improve effectiveness. Official information indicates that combining Reserpine with a diuretic or another antihypertensive medicine can result in a greater overall reduction in blood pressure. This combined approach increases the likelihood that patients will achieve their blood pressure goals compared to using Reserpine alone.


Q: What are the signs of a possible interaction with Reserpine that I should look out for?

A: Regulatory information notes that when combined with other blood pressure medicines, signs of excessive lowering of blood pressure (hypotension), such as marked dizziness or fainting, may occur. If combined with medicines that cause drowsiness, increased sedation is a documented possibility due to additive effects.


Q: Do official documents mention any effects of Reserpine on kidney function?

A: Official labeling addresses use in patients with existing kidney issues. Regulatory guidelines state that Reserpine is not recommended for patients who have renal impairment (poor kidney function). This is due to the potential for the body to eliminate the medicine at a slower rate than normal, which could prolong its effects.


Q: Is it normal to feel a little dizzy when first starting Reserpine?

A: Dizziness is listed in regulatory documents as a common side effect. The full effect of Reserpine on blood pressure takes time to build up in the body. However, adverse effects like dizziness can still occur during the initial phase of treatment.


Q: Does Reserpine have a Black Box Warning, and what does it relate to?

A: The medicine carries an explicit, critical warning regarding mental health. Although the term 'Black Box Warning' may not be present on all labels, the drug has a severe, prominent warning about the risk of Mental Depression. This adverse reaction may occur at any time during treatment and carries the critical risk of suicidal thoughts or actions, which is why official information mandates stopping the medicine if symptoms appear.


Q: Is Reserpine known to cause nightmares or sleep disturbances?

A: Official documents list effects on the Central Nervous System (CNS). The adverse reactions documented on the product label include CNS effects such as drowsiness and headache. These documented effects on the CNS can sometimes be associated with other sleep disturbances or changes in sleep patterns.

How should Reserpine be stored and disposed of?

Reserpine tablets must be stored at room temperature, away from both excess heat and moisture. The required temperature range for storage is generally between 15 C and 30 C (59 F and 86 F). To maintain stability, the medication must be kept in the container it came in with the cap tightly closed and protected from light.

For child safety, the medication must always be stored out of the sight and reach of children, with safety caps secured. Disposal of unused or expired Reserpine should follow official guidelines, with the preferred method being a medicine take-back program. If a take-back program is not available, disposal instructions may involve flushing the medication, as specified on the official FDA flush list.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Reserpine found in:

A-Z Index: